Radical Chemo-radiation (CRT) Protocols for Head and Neck Squamous Cell Carcinomas (HNSCC)

Radical Chemo-radiation (CRT) Protocols for Head and Neck Squamous Cell Carcinomas (HNSCC)

Bibliographic Details
Main Author:	Kushal Gupta
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Cancer Research, Statistics, and Treatment
Online Access:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=83;epage=104;aulast=Gupta

Similar Items

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
by: Masashi Shiiba, et al.
Published: (2010-04-01)

The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Asita Fazel, et al.
Published: (2020-03-01)

The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Che-Wei Wang, et al.
Published: (2024-02-01)

Predictive models for stage and risk classification in head and neck squamous cell carcinoma (HNSCC)
by: Sugandh Kumar, et al.
Published: (2020-09-01)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
by: Panagiota Economopoulou, et al.
Published: (2019-08-01)

Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
by: Patrick Weller, et al.
Published: (2014-01-01)

Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
by: Lei Gao, et al.
Published: (2022-08-01)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Treewut Rassamegevanon, et al.
Published: (2021-11-01)

Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
by: Eirini Pectasides, et al.
Published: (2014-01-01)

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
by: Shutong Liu, et al.
Published: (2017-09-01)

Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC)
by: Naoki Katase, et al.
Published: (2022-11-01)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
by: Andrew G. Sikora, et al.
Published: (2019-03-01)

Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation
by: Erik Haehl, et al.
Published: (2022-11-01)

A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC)
by: Ludmila Wintergerst, et al.
Published: (2018-12-01)

629-B Window of opportunity for durvalumab plus metformin trial in head & neck squamous cell carcinoma (HNSCC)
by: Madalina Tuluc, et al.
Published: (2023-11-01)

Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Eliane Ebnoether, et al.
Published: (2020-06-01)

Common mutations assay of KRAS and BRAF genes in patients affected with Head and neck squamous cell carcinoma (HNSCC)
by: Razieh Zarifian Yeganeh, et al.
Published: (2017-10-01)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
by: Alexander Rühle, et al.
Published: (2021-05-01)

Comprehensive Geriatric Assessment and Quality of Life Aspects in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Anna Winter, et al.
Published: (2023-09-01)

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Julia Siemert, et al.
Published: (2021-07-01)

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
by: Luciana O. Almeida, et al.
Published: (2014-01-01)

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
by: Kedar Kirtane, et al.
Published: (2018-12-01)

Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis
by: Shahnawaz Khijmatgar, et al.
Published: (2024-12-01)

Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Panagiota Economopoulou, et al.
Published: (2021-01-01)

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice
by: Matthias Brand, et al.
Published: (2020-12-01)

675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)
by: Yiran Zhang, et al.
Published: (2023-11-01)

BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
by: Annika C. Betzler, et al.
Published: (2023-01-01)

The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
by: Philipp Opitz, et al.
Published: (2018-07-01)

Searching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries
by: Nobrega Francisco G, et al.
Published: (2008-11-01)

Evaluation of correlation between CD44, radiotherapy response, and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)
by: Parul Dubey, et al.
Published: (2022-05-01)

Optimization of a Three-Dimensional Culturing Method for Assessing the Impact of Cisplatin on Notch Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Alinda Anameriç, et al.
Published: (2023-11-01)

Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study
by: Elena Guerini Rocco, et al.
Published: (2022-02-01)

Methylene tetrahydrofolate dehydrogenase 2 (MTHFD2) is overexpressed in head and neck squamous cell carcinoma (HNSCC) and correlated with patient’s poor prognosis
by: Sun Biqiang, et al.
Published: (2021-12-01)

FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: From radioresistant HNSCC cell line to integrated bioinformatics methods
by: Xiaojun Tang, et al.
Published: (2022-09-01)

80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC)
by: Matthew Loya, et al.
Published: (2023-11-01)

Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
by: Gunjan Guha, et al.
Published: (2015-01-01)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Marius Huehn, et al.
Published: (2021-11-01)

MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis
by: Segal-Eiras Amada, et al.
Published: (2006-10-01)

Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Omar Freihat, et al.
Published: (2020-08-01)

Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
by: Nabil F Saba, et al.
Published: (2020-01-01)